Molecular Modeling of Sulfonylmorpholinopyrimidines as the Ataxia Telangiectasis Mutated and RAD3-related (ATR) Protein Kinase Inhibitors by Computational Explorations

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|12|8|661-672

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.12, Iss.8, 2015-10, pp. : 661-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Ataxia Telangiectasia Mutated Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 10, 2014-08 ,pp. : 805-811

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR Analysis on ATR Protein Kinase Inhibitors Using CoMFA and CoMSIA

By  

Current Computer - Aided Drug Design, Vol. 10, Iss. 4, 2014-12 ,pp. : 327-334

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy

By  

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 139-153

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Modeling of Antimalarial Protein Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 2, 2016-02 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite